AARD vs CHCI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

AARD

56.3
AI Score
VS
CHCI Wins

CHCI

60.3
AI Score

Investment Advisor Scores

AARD

56score
Recommendation
HOLD

CHCI

60score
Recommendation
BUY

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric AARD CHCI Winner
Net Income -35.98M 17.05M CHCI
Operating Income -37.55M 11.93M CHCI
ROE -48.1% 24.4% CHCI
ROA -44.2% 20.1% CHCI
Total Assets 81.46M 84.96M CHCI
Cash 73.85M 31.28M AARD
Current Ratio 12.63 5.50 AARD

Relative Price Performance (Last 90 Days)

AARD 1M: -23.3% · 3M: -31.0% CHCI 1M: -15.7% · 3M: +14.8%

Current Technical Phase

AARD

Markdown
Sell / avoid

Price below a falling SMA50 (slope -12.7%), weak momentum, RSI 44

RSI (14): 43.8 · Price: $4.41

CHCI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 37

RSI (14): 37.3 · Price: $17.31

Fundamentals Snapshot

Metric AARD CHCI
Market Cap — —
Forward P/E -1.9 12.9
Trailing P/E — 7.4
Revenue (TTM) — —
Revenue Growth 0.0% 0.7%
Gross Margin — 0.3%
Operating Margin 0.0% 0.3%
EPS -3.21 2.35
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CHCI is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.